StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research note released on Wednesday. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of CO opened at $1.50 on Wednesday. The business’s 50-day moving average is $1.42 and its 200-day moving average is $1.35. The company has a market capitalization of $182.33 million, a price-to-earnings ratio of 2.34 and a beta of 0.16. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50.
About Global Cord Blood
Recommended Stories
- Five stocks we like better than Global Cord Blood
- What is the S&P/TSX Index?
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- Canada Bond Market Holiday: How to Invest and Trade
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- Most active stocks: Dollar volume vs share volume
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.